Rose Woodward – Founder and Patient Advocate

As co-founder of the Kidney Cancer Support Network, Rose has worked tirelessly for many years to ensure kidney cancer patients in the UK have access to high quality care and the best possible treatment options. A long-term patient/survivor of kidney cancer herself, Rose is now an experienced patient advocate sharing her knowledge, experience and providing a strong patient voice at a national and international level on behalf of the kidney cancer community. Rose is a committed advocate on behalf of kidney cancer patients who wish to be involved directly in decision-making relating to their own care and believes passionately that people directly affected by cancer, should be part of the design and provision of cancer services within the NHS.

Together with Julia Black and Clive Stone MBE, Rose led the “Fight for Life” campaign which provided practical and bespoke support to several hundred kidney cancer patients refused access to clinically effective kidney cancer treatments. The campaign was ultimately successful when N I C E agreed to review the criteria for End of Life cancer drugs and consequently in 2009, the first targeted therapies for kidney cancer were made available in the UK.

The principle of patients sharing experiences, exchanging information and supporting each other is why the KCSN is the biggest and most active support network for people affected by kidney cancer in the UK.

Rose is a founding member and volunteer Board Director of the International Kidney Cancer Coalition (IKCC) and also serves as a patient representative on the National Cancer Research Institute Bladder and Renal Cancer (NCRI) Clinical Studies Group, alongside leading renal cancer clinicians, scientists and healthcare professionals.

Julia Black – Head of Patient Support

An experienced patient advocate with over 10 years experience working on behalf of rare cancer patients. Julia began campaigning for fairer access to cancer drugs and treatments as the postcode lottery of access to cancer drugs first began to unfold. Since then Julia has worked on over 250 individual funding applications for patients desperate to access the treatments their clinicians wish to prescribe, the vast majority of which have been on behalf of kidney cancer patients.

In 2006 whilst helping Keith a kidney cancer patient receive NHS funding for sorafenib she met many kidney cancer patients all desperate to access clinically effective cancer drugs via the NHS, her path crossed with Rose Woodward and between them they founded the KCSN, the largest UK support network for people touched by kidney cancer.

Julia is also project lead for the International Kidney Cancer Coalition (IKCC); a global collaboration of national patient groups supporting those affected by kidney cancer. She is also a patient advocate for the Rarer Cancers Foundation.

Diagnosed herself with breast cancer in 2005 and 2008, Julia has undergone surgery and chemotherapy and understands how it feels to face a diagnosis of cancer. A passionate patient advocate who firmly believes patients have a stronger voice when working together and who should be involved in all aspects of their own care.

Sharon Deveson Kell BSc PhD MBA – Head of Medical Relations

Sharon is a clinical scientist with over 15 years’ experience working in the pharmaceutical industry, during which time she held a variety of roles in drug development, marketing, and senior management. She has been the global project manager on a number of clinical trials involving biologics, and she has a good understanding of the drug development process.

During her pharmaceutical career, she was responsible for writing clinical study protocols and reports, patient information leaflets, and scientific papers. She was involved with writing and implementing training programmes for clinical researchers and project managers, and organising and running investigator meetings for clinical trial programmes. In her current role as a medical writer she has written numerous factsheets and booklets for cancer patients, and organised cancer patient meetings. She has also part written and project managed an online renal cancer course for nurses.

Sharon has a first class honours degree in physiology and biochemistry from Reading University, and a doctorate in reproductive endocrinology from the University of Surrey. She achieved her MBA from the Open University in May 2000.

Volunteers and supporters

At KCSN everyone plays a part; we work together in a variety of ways to offer help and support. The KCSN charity couldn’t achieve half of what we do without the kindness and commitment of our many volunteers, and the generous donations and fundraising endeavours of our fellow kidney cancer patients, carers, families and friends.  Thank you!

  TOP